Page 2148 - Hematology_ Basic Principles and Practice ( PDFDrive )

1905.e4 Part XII Hemostasis and Thrombosis

154. Huang ZF, Higuchi D, Lasky N, et al: Tissue factor pathway inhibitor 178. Weisdorf DJ, Edson JR: Recurrent venous thrombosis associated
gene disruption produces intrauterine lethality in mice. Blood 90:944, with inherited deficiency of heparin cofactor II. Br J Haematol 77:125,
1997. 1991.
155. Golino P, Ragni M, Cimmino G, et al: Role of tissue factor pathway 179. Corral J, Aznar J, Gonzalez-Conejero R, et al: Homozygous deficiency
inhibitor in the regulation of tissue factor-dependent blood coagulation. of heparin cofactor II: relevance of P17 glutamate residue in serpins,
Cardiovasc Drug Rev 20:67, 2002. relationship with conformational diseases, and role in thrombosis.
156. Kato H: Regulation of functions of vascular wall cells by tissue factor Circulation 110:1303, 2004.
pathway inhibitor: basic and clinical aspects. Arterioscler Thromb Vasc 180. Suzuki K, Nishioka J, Hashimoto S: Protein C inhibitor. Purification
Biol 22:539, 2002. from human plasma and characterization. J Biol Chem 258:163, 1983.
157. Amirkhosravi A, Meyer T, Amaya M, et al: The role of tissue factor 181. Laurell M, Christensson A, Abrahamsson PA, et al: Protein C inhibitor
pathway inhibitor in tumor growth and metastasis. Semin Thromb in human body fluids. Seminal plasma is rich in inhibitor antigen
Hemost 33:643, 2007. deriving from cells throughout the male reproductive system. J Clin
158. Hackeng TM, Rosing J: Protein S as cofactor for TFPI. Arterioscler Invest 89:1094, 1992.
Thromb Vasc Biol 29:2015, 2009. 182. Laurell M, Stenflo J, Carlson TH: Turnover of *I-protein C inhibitor
159. DelGiudice LA, White GA: The role of tissue factor and tissue factor and *I-alpha 1-antitrypsin and their complexes with activated protein
pathway inhibitor in health and disease states. J Vet Emerg Crit Care C. Blood 76:2290, 1990.
(San Antonio) 19:23, 2009. 183. Geiger M, Zechmeister-Machhart M, Uhrin P, et al: Protein C inhibitor
160. Kasthuri RS, Glover SL, Boles J, et al: Tissue factor and tissue factor (PCI). Immunopharmacology 32:53, 1996.
pathway inhibitor as key regulators of global hemostasis: measurement 184. Seregni E, Botti C, Ballabio G, et al: Biochemical characteristics and
of their levels in coagulation assays. Semin Thromb Hemost 36:764, recent biological knowledge on prostate-specific antigen. Tumori 82:72,
2010. 1996.
161. Chan JC, Carmeliet P, Moons L, et al: Factor VII deficiency rescues 185. Heeb MJ, Espana F, Griffin JH: Inhibition and complexation of
the intrauterine lethality in mice associated with a tissue factor pathway activated protein C by two major inhibitors in plasma. Blood 73:446,
inhibitor deficit. J Clin Invest 103:475, 1999. 1989.
162. van ’t Veer C, Golden NJ, Kalafatis M, et al: Inhibitory mechanism of 186. Hoogendoorn H, Nesheim ME, Giles AR: A qualitative and quantita-
the protein C pathway on tissue factor-induced thrombin generation. tive analysis of the activation and inactivation of protein C in vivo in
Synergistic effect in combination with tissue factor pathway inhibitor. a primate model. Blood 75:2164, 1990.
J Biol Chem 272:7983, 1997. 187. Espana F, Vicente V, Tabernero D, et al: Determination of plasma
163. Eitzman DT, Westrick RJ, Bi X, et al: Lethal perinatal thrombosis in protein C inhibitor and of two activated protein C-inhibitor complexes
mice resulting from the interaction of tissue factor pathway inhibitor in normals and in patients with intravascular coagulation and throm-
deficiency and factor V Leiden. Circulation 105:2139, 2002. botic disease. Thromb Res 59:593, 1990.
164. Westrick RJ, Bodary PF, Xu Z, et al: Deficiency of tissue factor pathway 188. Mosnier LO, Elisen MG, Bouma BN, et al: Protein C inhibitor regu-
inhibitor promotes atherosclerosis and thrombosis in mice. Circulation lates the thrombin-thrombomodulin complex in the up- and down
103:3044, 2001. regulation of TAFI activation. Thromb Haemost 86:1057, 2001.
165. Crawley JT, Lane DA: The haemostatic role of tissue factor pathway 189. Strandberg K, Astermark J, Bjorgell O, et al: Complexes between acti-
inhibitor. Arterioscler Thromb Vasc Biol 28:233, 2008. vated protein C and protein C inhibitor measured with a new method:
166. Tollefsen DM, Majerus DW, Blank MK: Heparin cofactor II. Purifica- comparison of performance with other markers of hypercoagulability
tion and properties of a heparin-dependent inhibitor of thrombin in in the diagnosis of deep vein thrombosis. Thromb Haemost 86:1400,
human plasma. J Biol Chem 257:2162, 1982. 2001.
167. Griffith MJ, Carraway T, White GC, et al: Heparin cofactor activities 190. Meijers JC, Kanters DH, Vlooswijk RA, et al: Inactivation of human
in a family with hereditary antithrombin III deficiency: evidence for a plasma kallikrein and factor XIa by protein C inhibitor. Biochemistry
second heparin cofactor in human plasma. Blood 61:111, 1983. 27:4231, 1988.
168. Tollefsen DM, Pestka CA, Monafo WJ: Activation of heparin cofactor 191. Sottrup-Jensen L: Alpha 2-macroglobulin and related thiol ester proteins.
II by dermatan sulfate. J Biol Chem 258:6713, 1983. In Putnam FW, editor: The plasma proteins, Olando, 1987, Academic
169. Parker KA, Tollefsen DM: The protease specificity of heparin cofactor Press, p 191.
II. Inhibition of thrombin generated during coagulation. J Biol Chem 192. Travis J, Salvesen GS: Human plasma proteinase inhibitors. Annu Rev
260:3501, 1985. Biochem 52:655, 1983.
170. Giri TK, Ahn CW, Wu KK, et al: Heparin cofactor II levels do not 193. Pizzo SV, Gonias SL: Receptor-mediated protease regulation. In
predict the development of coronary heart disease: the Atherosclerosis Conn PM, editor: The receptors, Orlando, 1984, Academic Press,
Risk in Communities (ARIC) study. Arterioscler Thromb Vasc Biol p 177.
25:2689, 2005. 194. Swenson RP, Howard JB: Structural characterization of human alpha2-
171. McGuire EA, Tollefsen DM: Activation of heparin cofactor II by macroglobulin subunits. J Biol Chem 254:4452, 1979.
fibroblasts and vascular smooth muscle cells. J Biol Chem 262:169, 195. Sottrup-Jensen L, Stepanik TM, Wierzbicki DM, et al: The primary
1987. structure of alpha 2-macroglobulin and localization of a Factor XIIIa
172. Church FC, Pratt CW, Hoffman M: Leukocyte chemoattractant pep- cross-linking site. Ann N Y Acad Sci 421:41, 1983.
tides from the serpin heparin cofactor II. J Biol Chem 266:704, 1991. 196. Kan CC, Solomon E, Belt KT, et al: Nucleotide sequence of cDNA
173. Andrew M, Mitchell L, Berry L, et al: An anticoagulant dermatan encoding human alpha 2-macroglobulin and assignment of the chro-
sulfate proteoglycan circulates in the pregnant woman and her fetus. J mosomal locus. Proc Natl Acad Sci USA 82:2282, 1985.
Clin Invest 89:321, 1992. 197. Carlsson-Bosted L, Moestrup SK, Gliemann J, et al: Three different
174. Massouh M, Jatoi A, Gordon EM, et al: Heparin cofactor II activity in conformational states of pregnancy zone protein identified by mono-
plasma during pregnancy and oral contraceptive use. J Lab Clin Med clonal antibodies. J Biol Chem 263:6738, 1988.
114:697, 1989. 198. Christensen U, Simonsen M, Harrit N, et al: Pregnancy zone protein,
175. Liu L, Dewar L, Song Y, et al: Inhibition of thrombin by antithrombin a proteinase-binding macroglobulin. Interactions with proteinases and
III and heparin cofactor II in vivo. Thromb Haemost 73:405, 1995. methylamine. Biochemistry 28:9324, 1989.
176. Andersson TR, Sie P, Pelzer H, et al: Elevated levels of thrombin- 199. Barrett AJ, Starkey PM: The interaction of alpha 2-macroglobulin
heparin cofactor II complex in plasma from patients with disseminated with proteinases. Characteristics and specificity of the reaction, and a
intravascular coagulation. Thromb Res 66:591, 1992. hypothesis concerning its molecular mechanism. Biochem J 133:709,
177. Simioni P, Lazzaro AR, Coser E, et al: Hereditary heparin cofactor 1973.
II deficiency and thrombosis: report of six patients belonging to two 200. Harpel PC: Human plasma alpha 2-macroglobulin. An inhibitor of
separate kindreds. Blood Coagul Fibrinolysis 1:351, 1990. plasma kallikrein. J Exp Med 132:329, 1970.